
NVS Looks 22.5% Overvalued on GF Value™ Amid Dividend Sustainability Focus
On September 07, 2026, Novartis AG (NYSE: NVS) faced a setback as its cardiovascular drug pelacarsen failed to meet the primary endpoint in the Phase 3 HORIZON
AIVAA™ — OUR AI VALUES YOUR PROPERTY IN MINUTES. NO $3,000 APPRAISAL, NO THREE-WEEK WAIT
Insights
8 timely updates from finance news, commercial-real-estate RSS headlines, and St. Louis Fed macro indicators. For context only — not investment advice.

On September 07, 2026, Novartis AG (NYSE: NVS) faced a setback as its cardiovascular drug pelacarsen failed to meet the primary endpoint in the Phase 3 HORIZON

Ares Capital remains a top BDC pick with a 9.6% yield, strong dividend coverage, and resilient credit metrics. Click here to get the latest ARCC outlook now.

Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
Latest observation as of 2026-09-03 for FRED series DGS10.
Latest observation as of 2026-09-03 for FRED series MORTGAGE30US.
Latest observation as of 2026-09-03 for FRED series SOFR.
Latest observation as of 2026-08-01 for FRED series FEDFUNDS.
Latest observation as of 2026-04-01 for FRED series DRCRELEXFACBS.